|
|||||
 |
 |
 |
 |
 |
|
 |
|||||
| Faculty |
||
 |
||
Paul Edelstein, M.D. Dr. Edelstein is the Director of the Clinical Microbiology Laboratory. His current areas of interest include Legionnaires disease, molecular pathogenesis of bacterial infections, pneumonia, and antimicrobial chemotherapy. Edelstein PH, Hu B, Shinzato T, Edelstein MAC, Xu W, Bessman MJ. Legionella pneumophila NudA is a Nudix hydrolase and virulence factor. Infect Immun 2005;73:6567-6576. Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis 2005;41:923-929. Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006;24: 468-475. Connolly LE, Edelstein PH, Ramakrishnan L. Why is long-term therapy required to cure tuberculosis? PLOS Medicine 2007, in press. Contact:
Education: |
||
